Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Evaluator-blinded, No-treatment Controlled, Multicenter Study to Evaluate the Effectiveness and Safety of Restylane Skinboosters Vital Lidocaine for Improvement in Skin Quality of the Face

NCT07047638 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.

NCT NCT07047638
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07047638 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Evaluator-blinded, No-treatment Controlled, Multicenter Study to Evaluate the Effectiveness and Safety of Restylane Skinboosters Vital Lidocaine for Improvement in Skin Quality of the Face
Lead sponsor
Galderma R&D
Phase
Not applicable
Overall status
Active, not recruiting
Start date
July 9, 2025
Completion date
July 31, 2027
Enrollment
171 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

skin quality improvement